Shiao-Pei S. Weathers, MD on Phase I/II of Autologous CMV-Specific Cytotoxic T Cells: What’s Next? @MDAndersonNews

Shiao-Pei S. Weathers, MD of MD Anderson Cancer Center @MDAndersonNews discusses phase I/II clinical trial of autologous CMV-specific cytotoxic t-cells for GBM patients

https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2014-0899.html